44 results
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
regulations or third-party coverage and reimbursement policies, which would harm our business.
In the United States and in other countries, patients who … with their treatment. We believe our success depends in part on obtaining and maintaining coverage and adequate reimbursement for our product candidates
8-K
EX-10.1
09obduah9gfh2
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
8-K
EX-10.1
zpzwpmabm 86br2ay03
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K
EX-10.1
ylsvl
5 Jan 24
Departure of Directors or Certain Officers
4:39pm
8-K/A
EX-99.1
9ua4l67zk88i6v9 k2
14 Aug 23
Completion of Acquisition or Disposition of Assets
5:55pm
8-K
EX-10.1
i1rtm
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
8-K
EX-99.2
9j6d kxv2qpw2w64z7
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
8-K
EX-3.2
ct9l0tml1ja
20 Jul 23
Entry into a Material Definitive Agreement
5:21pm
425
l0f446xkw0 kdit
10 Jul 23
Business combination disclosure
8:03am
8-K
EX-10.1
x50qejw6389do8k4lj5
10 Jul 23
Entry into a Material Definitive Agreement
8:00am